Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study : SIMPLICITY - Mauro, Michael J.; Hehlmann, Rüdiger; Williams, Loretta A.; Goldberg, Stuart L.; Michallet, Mauricette; Gambacorti-Passerini, Carlo; Tang, Derek; DeGutis, Irene S.; McBride, Ali; Parsons, Lori; Montelongo, Monica; Cortes, Jorge E. (Leukemia and lymphoma, 2025)
Gesehen am 02.10.2025